Acquired Neuromuscular Disorders: Pathogenesis,... «Trusted Source»

Treatment for acquired NMDs is largely clinically oriented and tailored to the specific etiology:

: Identifying specific autoantibodies is crucial for confirming autoimmune NMDs like Myasthenia Gravis. Acquired Neuromuscular Disorders: Pathogenesis,...

: Electromyography (EMG) and nerve conduction studies are used to distinguish between primary muscle issues (myopathies) and nerve issues (neuropathies). Treatment for acquired NMDs is largely clinically oriented

: Certain drugs, such as statins or cancer treatments, can induce Statin Myopathies or toxic neuropathies by interfering with cellular metabolism or inducing oxidative stress. Pathogenesis of Acquired NMDs The underlying mechanisms of

: Cancer-related immune responses can cross-react with neuromuscular components, leading to specialized paraneoplastic syndromes. Diagnostic Framework

Acquired neuromuscular disorders (NMDs) encompass a broad spectrum of conditions affecting the peripheral nerves, muscles, and neuromuscular junctions that are not inherited genetically but rather developed through life . These disorders often stem from inflammatory, autoimmune, or toxic triggers, becoming increasingly prevalent in aging populations due to factors like medication side effects (e.g., statins) or paraneoplastic syndromes. Pathogenesis of Acquired NMDs

The underlying mechanisms of acquired neuromuscular disorders typically involve an immune-mediated or metabolic disruption of the motor system: